Clusterin gene (CLU) has been identified as a susceptibility genetic locus for a late-onset AD by genome-wide association studies (GWASs) and a meta-analysis [181], prompting research on the potential utility of CLU as a prediction marker for other NDDs, including PD [182,183]. This evidence concerns the gene CLU and Alzheimer disease.